Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Zomedica Corp. ZOM

Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is currently focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its operations are comprised of two reportable segments: Diagnostic & Therapeutics. It earns the majority of revenue from the therapeutics segment.


Recent & Breaking News (NYSEAM:ZOM)

Zomedica Pharmaceuticals Corp. Expects Trading of its Common Shares on the NYSE American to Commence on November 21, 2017

GlobeNewswire November 16, 2017

Zomedica Pharma approved for listing by NYSE American

Stockhouse Editorial November 10, 2017

Zomedica Pharmaceuticals Corp. Announces NYSE American Listing Approval

GlobeNewswire November 10, 2017

Zomedica Pharmaceuticals Corp. Announces Third Quarter 2017 Financial Results

GlobeNewswire November 9, 2017

Zomedica Pharmaceuticals Corp. to Present at Jefferies 2017 London Healthcare Conference and LD Micro Main Event 2017

GlobeNewswire November 8, 2017

Zomedica Pharmaceuticals Corp. Announces US$5M Unsecured Working Capital Loan Facility

GlobeNewswire October 18, 2017

Zomedica Pharmaceuticals Corp. Amends Quorum Requirement for Shareholder Meetings

GlobeNewswire September 21, 2017

Zomedica Pharmaceuticals Corp. to Present at SeeThruEquity and RHK Capital 2017 Disruptive Growth Company Showcase NYC

GlobeNewswire September 21, 2017

Zomedica Appoints PCG Advisory Group for Investor Relations and Announces Option Grants

GlobeNewswire August 14, 2017

Zomedica Pharmaceuticals Corp. Announces Second Quarter 2017 Financial Results

GlobeNewswire August 10, 2017

Zomedica Raises C$4.13 Million in First Tranche Closing of Equity Financing

GlobeNewswire July 28, 2017

Zomedica Strengthens Executive Leadership Team

GlobeNewswire July 10, 2017

Zomedica Pharmaceuticals Corp. to Present at The MicroCap Conference on June 27 in Toronto at the Sheraton Centre Hotel

Accesswire June 20, 2017

Zomedica Pharmaceuticals Corp. to Present at The MicroCap Conference 2017 in Toronto

GlobeNewswire June 20, 2017

Zomedica Announces 2017 Annual Meeting Results

GlobeNewswire June 2, 2017

Zomedica Pharmaceuticals Corp. Announces First Quarter 2017 Financial Results

GlobeNewswire May 11, 2017

Zomedica Announces Adoption of Advance Notice Bylaw

GlobeNewswire April 28, 2017

Zomedica Pharmaceuticals Corp. To Present at PIONEERS 2017, Presented by Joseph Gunnar & Co.

GlobeNewswire April 25, 2017

Zomedica Pharmaceuticals Corp. Files U.S. Registration Statement for Secondary Sales by Selling Shareholders

GlobeNewswire April 24, 2017

Zomedica Raises C$4.35 Million in Second Tranche Closing of Equity Financing for Aggregate Proceeds of C$5.54 Million

GlobeNewswire April 10, 2017